Anne Chiffoleau

649 total citations
39 papers, 361 citations indexed

About

Anne Chiffoleau is a scholar working on Geriatrics and Gerontology, Oncology and Pharmacology. According to data from OpenAlex, Anne Chiffoleau has authored 39 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Geriatrics and Gerontology, 6 papers in Oncology and 5 papers in Pharmacology. Recurrent topics in Anne Chiffoleau's work include Pharmaceutical Practices and Patient Outcomes (6 papers), Pharmacovigilance and Adverse Drug Reactions (5 papers) and Urticaria and Related Conditions (3 papers). Anne Chiffoleau is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (6 papers), Pharmacovigilance and Adverse Drug Reactions (5 papers) and Urticaria and Related Conditions (3 papers). Anne Chiffoleau collaborates with scholars based in France, Puerto Rico and Zambia. Anne Chiffoleau's co-authors include Nathalie Asseray, Françoise Ballereau, G. Potel, Brigitte Dréno, Jean-Benoît Hardouin, Yves Maugars, Jean‐Marie Berthelot, Pascale Jolliet, C Larousse and G. Veyrac and has published in prestigious journals such as Blood, Antimicrobial Agents and Chemotherapy and International Journal of Environmental Research and Public Health.

In The Last Decade

Anne Chiffoleau

37 papers receiving 348 citations

Peers

Anne Chiffoleau

HEMAT

TOXIC

PHARM

Binu Mathew India

Margaux Lafaurie France

R ROBERTS United States

A. Scott Mathis United States

Lee Curtis United Kingdom

Ian Boyd Australia

Betsy J. Lahue United States

Benjamin Batteux France

Helene Skjøt‐Arkil Denmark

John Coutsouvelis Australia

Binu Mathew India

Anne Chiffoleau

50 ×0.7

28 ×0.4

14 ×0.3

HEMAT

9 ×0.2

TOXIC

74 ×1.6

PHARM

Citations per year, relative to Anne Chiffoleau Anne Chiffoleau (= 1×) peers Binu Mathew

Countries citing papers authored by Anne Chiffoleau

Since Specialization

Citations

This map shows the geographic impact of Anne Chiffoleau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Chiffoleau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Chiffoleau more than expected).

Fields of papers citing papers by Anne Chiffoleau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Chiffoleau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Chiffoleau. The network helps show where Anne Chiffoleau may publish in the future.

Co-authorship network of co-authors of Anne Chiffoleau

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Chiffoleau. A scholar is included among the top collaborators of Anne Chiffoleau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Chiffoleau. Anne Chiffoleau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Péréon, Yann, Maxime Leroy, Olivier Lépine, et al.. (2023). PROPERTY: study protocol for a randomized, double-blind, multicenter placebo-controlled trial assessing neurotoxicity in patients with metastatic gastrointestinal cancer taking PHYCOCARE® during oxaliplatin-based chemotherapy. Trials. 24(1). 50–50. 4 indexed citations

Gaborit, Benjamin, Éric Dailly, Bernard Vanhove, et al.. (2021). Pharmacokinetics and Safety of XAV-19, a Swine Glyco-humanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-Related Moderate Pneumonia: a Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study. Antimicrobial Agents and Chemotherapy. 65(9). e0123721–e0123721. 9 indexed citations

Nguyen, Jean‐Michel, L. Machet, Jean‐Paul Claudel, et al.. (2020). FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial. Trials. 21(1). 571–571. 14 indexed citations

Trang-Poisson, Caroline, Lucie Planche, Harry Sokol, et al.. (2020). Impact of fecal microbiota transplantation on chronic recurrent pouchitis in ulcerative colitis with ileo-anal anastomosis: study protocol for a prospective, multicenter, double-blind, randomized, controlled trial. Trials. 21(1). 455–455. 3 indexed citations

Volteau, Christelle, Marie‐Laure Le Lez, Marie‐Hélène Errera, et al.. (2020). Comparison of two techniques used in routine care for the treatment of inflammatory macular oedema, subconjunctival triamcinolone injection and intravitreal dexamethasone implant: medical and economic importance of this randomized controlled trial. Trials. 21(1). 159–159. 10 indexed citations

Volteau, Christelle, et al.. (2020). Does internal limiting membrane peeling during epiretinal membrane surgery induce microscotomas on microperimetry? Study protocol for PEELING, a randomized controlled clinical trial. Trials. 21(1). 500–500. 3 indexed citations

Crépin, Sabrina, Anne Chiffoleau, Pascale Olivier, et al.. (2020). Compliance of French academic clinical trials with the Clinical Trial Facilitation and Coordination Group recommendations on contraception and pregnancy testing requirements. Clinical Trials. 17(3). 314–322. 2 indexed citations

Perrot, Pierre, Jean‐Michel Nguyen, Soraya Saïagh, et al.. (2019). CICAFAST: comparison of a biological dressing composed of fetal fibroblasts and keratinocytes on a split-thickness skin graft donor site versus a traditional dressing: a randomized controlled trial. Trials. 20(1). 612–612. 9 indexed citations

Vourc’h, Mickaël, Fanny Feuillet, Anne Chiffoleau, et al.. (2019). Preoxygenation in difficult airway management: high-flow oxygenation by nasal cannula versus face mask (the PREOPTIDAM study). Protocol for a single-centre randomised study. BMJ Open. 9(4). e025909–e025909. 9 indexed citations

10.

Venara, Aurélien, J. Podevin, Philippe Godeberge, et al.. (2018). A comparison of surgical devices for grade II and III hemorrhoidal disease. Results from the LigaLongo Trial comparing transanal Doppler-guided hemorrhoidal artery ligation with mucopexy and circular stapled hemorrhoidopexy. International Journal of Colorectal Disease. 33(10). 1479–1483. 9 indexed citations

11.

Ballereau, Françoise, et al.. (2014). Adverse Drug Event Nonrecognition in Emergency Departments: An Exploratory Study on Factors Related to Patients and Drugs. Journal of Emergency Medicine. 46(6). 857–864. 20 indexed citations

12.

Peuvrel, L., Anne Chiffoleau, G. Quéreux, et al.. (2013). Melanoma and Rituximab: An Incidental Association?. Dermatology. 226(3). 274–278. 18 indexed citations

13.

Asseray, Nathalie, et al.. (2012). Implementing a clinical pharmacy survey of adverse drug events in a French emergency department. International Journal of Clinical Pharmacy. 34(6). 902–910. 13 indexed citations

14.

Asseray, Nathalie, et al.. (2011). Consommation de jus de pamplemousse et risque d’interactions médicamenteuses : étude transversale dans un service d’urgences médicales. Therapies. 66(5). 421–429. 4 indexed citations

15.

Berthelot, Jean‐Marie, et al.. (2003). Informing patients about serious side effects of drugs. A 2001 survey of 341 French rheumatologists. Joint Bone Spine. 70(1). 52–57. 7 indexed citations

16.

Berthelot, Jean‐Marie, et al.. (2003). L’information du patient des effets indésirables graves des traitements : résultat d’un sondage réalisé auprès de 341 rhumatologues français en 2001. Revue du Rhumatisme. 70(1). 58–64. 1 indexed citations

17.

Veyrac, G., et al.. (2002). [Characteristics of hypersensitivity syndrome to lamotrigine: review of one case reported in the Regional Center of Pharmacovigilance of Nantes].. PubMed. 57(3). 289–96. 14 indexed citations

18.

Veyrac, G., Anne Chiffoleau, L. Cellerin, C Larousse, & Michel Bourin. (2000). [Latanoprost (Xalatan) and a systemic respiratory effect? Apropos of a case].. PubMed. 54(4). 494–6. 1 indexed citations

19.

Berthelot, Jean‐Marie, Joëlle Glémarec, Anne Chiffoleau, Yves Maugars, & A Prost. (1997). [Treatment with low dose methotrexate in rheumatoid arthritis: risk factors for severe complications].. PubMed. 52(2). 111–6. 4 indexed citations

20.

Poinsignon, Yves, et al.. (1994). Neutropénie à l'acénocoumarol associée à une leucémie à tricholeucocytes. La Revue de Médecine Interne. 15(7). 479–480. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact